Randomized Controlled Trial
Copyright ©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1458-1467
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1458
Table 1 Baseline characteristics of enrolled patients with liver cirrhosis and healthy controls
Variable
Healthy control subjects
Liver cirrhosis patients
P value
Participants (n)3070-
Age (year)53 ± 6.256.1 ± 5.10.199
Women, n (%)14 (46.7)31 (44.3)0.826
BMI (kg/m2)24.8 ± 4.122.5 ± 3.70.413
Energy intake (kcal/day)2443 ± 4732264 ± 6420.031
TBW (L)40.04 ± 6.6740.25 ± 9.380.221
ICW (L)26.84 ± 6.3625.62 ± 6.320.316
ECW (L)14.81 ± 2.5014.63 ± 3.410.332
TBP (kg)10.91 ± 1.8011.09 ± 2.730.153
Mineral (kg)3.67 ± 0.614.03± 1.070.341
BFM (kg)21.27 ± 6.7414.38 ± 6.63< 0.001
SMM (kg)33.91 ± 5.4921.42 ± 8.22< 0.001
FFM (kg)54.63 ± 3.0848.02 ± 3.85< 0.001
PBF (%)27.77 ± 7.5020.37 ± 8.130.227
WHR0.90 ± 0.050.83 ± 0.140.612
VFA (cm2)95.61 ± 3.7866.32 ± 3.50< 0.001
BCM (kg)36.16 ± 3.0431.72 ± 2.02< 0.001
Table 2 Basic information of patients with liver cirrhosis in the normal diet and nocturnal snacks groups
Variable
Normal diet group
Nocturnal snacks group
P value
Patients (n)3535-
Age (year)54.8 ± 4.957.3 ± 4.70.173
Women, n (%)13 (37.1)18 (51.4)0.229
BMI (kg/m2)24.8 ± 3.924.60 ± 2.90.611
Pathogenesis, n (%)0.444
HBV21 (60.0)26 (74.3)
HCV6 (17.1)4 (11.4)
Alcoholic8 (22.9)5 (14.3)
ALT (IU/L)72.3 ± 64.789.6 ± 73.50.586
AST (IU/L)89 (37,153)82 (41,160)0.510
Albumin (g/L)35.6 ± 6.835.1 ± 6.50.824
Total bilirubin (μmol/L)129 (43,215)112 (41,224)0.786
Prothrombin time (s)16.8 ± 7.415.5 ± 6.10.572
INR1.48 ± 0.61.37 ± 0.50.578
Urea nitrogen (mmol/L)8.0 ± 2.36.0 ± 2.10.520
Serum creatinine (μmol/L)56.9 ± 11.359.9 ± 15.10.509
Ascites, n (%)24 (68.6)27 (77.1)0.420
Child–Turcotte–Pugh, n (%)0.939
A5 (14.3)6 (17.1)
B15 (42.9)14 (40.0)
C15 (42.9)15 (42.9)
Table 3 Comparison of body composition before intervention between the normal diet and nocturnal snacks groups
Body composition indexes
Normal diet group (n = 35)
Nocturnal snacks group (n = 35)
P value
TBW (L)39.73 ± 7.1441.80 ± 7.100.414
ICW (L)25.14 ± 4.3326.24 ± 2.640.309
ECW (L)14.59 ± 2.4115.56 ± 2.790.229
ECW/TBW (%)37.62 ± 3.2237.22 ± 4.170.332
TBP (kg)12.09 ± 2.7310.73 ± 1.880.479
Mineral (kg)7.07 ± 3.125.97 ± 2.680.872
BFM (kg)13.72 ± 2.2315.71 ± 3.160.178
SMM (kg)22.19 ± 2.1920.38 ± 2.650.520
FFM (kg)50.21 ± 2.1747.52 ± 2.640.509
PBF (%)21.19 ± 7.1919.48 ± 4.160.711
WHR0.81 ± 0.240.84 ± 0.060.332
VFA (cm2)67.12 ± 1.1765.93 ± 2.670.175
BCM (kg)30.33 ± 1.0232.16 ± 1.210.648
Table 4 Survey of daily activity levels of the two groups during the intervention, n (%)
Daily activity volume
Normal diet group (n = 35)
Nocturnal snacks group (n = 35)
P value
Low-level activity9 (25.7)9 (25.7)0.921
Medium-level activity23 (65.7)22 (62.9)
High-level of activity3 (8.6)4 (11.4)
Table 5 Comparison of basic information of patients with liver cirrhosis in the normal diet and nocturnal snacks groups at the end of the observation
Variable
Normal diet group (n = 35)
Nocturnal snacks group (n = 35)
P value
ALT (IU/L)31.5 ± 10.629.0 ± 11.20.615
AST (IU/L)38.1 ± 19.239.1 ± 13.30.894
Albumin (g/L)34.6 ± 4.334.1 ± 4.70.762
Total bilirubin (μmol/L)29.9 ± 25.819.2 ± 10.20.238
Prothrombin time (s)13.5 ± 2.613.5 ± 1.70.732
INR1.2 ± 0.21.3 ± 0.20.723
Urea nitrogen (mmol/L)5.4 ± 2.74.9 ± 0.90.582
Serum creatinine (μmol/L)69.1 ± 12.165.7 ± 12.00.537
Ascites, n (%)22 (62.9)23 (65.7)0.803
Child–Turcotte–Pugh, n (%)0.945
A7 (20.0)6 (17.1)
B15 (42.9)15 (42.9)
C13 (37.1)14 (40.0)